Ron Stotish  Executive Director, Chief Executive Officer

Ronald L. Stotish, Ph.D. was named CEO and President of Aqua Bounty Technologies in May 2008. Ron joined Aqua Bounty Technologies in 2006 as Vice President for Regulatory Affairs, and most recently was Senior Vice President for R&D and Regulatory Affairs. Prior to joining Aqua Bounty, Ron was Executive Vice President for R&D at MetaMorphix, Inc. He has served as Vice President for Pharmaceutical Research and Development at Fort Dodge Animal Health, and held a variety of positions at American Cyanamid. He began his career in basic research at Merck. Ron has degrees in Biochemistry, and over thirty five years experience in the discovery, development, and commercialization of new animal health products.

Back to chart